PMC:7204663 / 253-453 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T4","span":{"begin":107,"end":108},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"nt communication discusses some common pharmacokinetic properties of these two drugs that may be linked to a potential underlying mechanism of action for these antiviral effects. The physicochemical p"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":79,"end":84},"obj":"Chemical"},{"id":"T7","span":{"begin":160,"end":169},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"nt communication discusses some common pharmacokinetic properties of these two drugs that may be linked to a potential underlying mechanism of action for these antiviral effects. The physicochemical p"}